Cargando…
126. evaluation of Addition of Outpatient Parenteral Antimicrobial Therapy and Orthopedic ID Resources to Transitions-of-care Outcomes
BACKGROUND: Our large academic medical center initiated both an Outpatient Parenteral Antimicrobial Therapy (OPAT) program supported by an infectious disease trained pharmacist, along with an Orthopedic Infectious Disease (OID) consult service to assist in caring for these specialized populations. W...
Autores principales: | Young, Brett, Bergman, Scott, Van Schooneveld, Trevor C, Cortes-Penfield, Nicolas W, Alexander, Bryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778105/ http://dx.doi.org/10.1093/ofid/ofaa439.436 |
Ejemplares similares
-
101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023) -
Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023) -
In Outpatients Receiving Parenteral Vancomycin, Dosing Adjustments Produced by Area Under the Curve-Based and Trough-Based Monitoring Differ Only at the Extremes of the Therapeutic Trough Range
por: Shi, Yufei, et al.
Publicado: (2023) -
624. Significant Institutional Cost Savings from OPAT-Facilitated Discharge for Patients with Challenging Situations
por: Alexander, Bryan, et al.
Publicado: (2020) -
Outpatient parenteral antimicrobial therapy for orthopedic infections – a successful public healthcare experience in Brazil
por: Oliveira, Priscila Rosalba, et al.
Publicado: (2016)